Skip to main content

Table 1 Patient Characteristics of 268 untreated adult patients with Pompe disease

From: Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy

Female, n (%)

141 (53)

Median age at study entry, years (range)

48 (19-79)

Median age at diagnosis, years (range)

38 (1-68)

Number of patients diagnosed in age categories of 15 years, n (%)

 

   <15 years

22 (8)

   16-30 years

59 (22)

   31-45 years

115 (43)

   46-60 years

61 (23)

   >61 years

11 (4)

Nationality, n (%)

 

   Netherlands

99 (37)

   Germany

48 (18)

   US

69 (26)

   UK

20 (8)

   Australia

13 (5)

   Canada

9 (3)

   Other

10 (4)

Median disease duration at entry, years (range)

9 (0-32)

Median follow up time, years (range)

3.5 (0.02-7)

Disability level at study entry, n (%)

 

   No wheelchair use or respiratory supportª

127 (47)

   Wheelchair use

34 (13)

   Use of respiratory support

39 (15)

   Both wheelchair use and respiratory support

68 (25)

Median RHS score* at study entry (range) (n = 258)

27 (9-36)

  1. Continuous variables are expressed as median (range). Categorical variables are expressed as n (%). ª'Respiratory support' includes partial and fulltime, invasive and non-invasive respiratory support *RHS assesses the level of participation/handicap; score varies between 9 (severe participation restrictions) and 36 (no participation restrictions).